about
Biology of bone metastases.Role of Osteogenic Growth Peptide (OGP) and OGP(10-14) in Bone Regeneration: A ReviewRGS expression in cancer: oncomining the cancer microarray data.Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.Endothelin receptors: what's new and what do we need to know?Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.Anti-endothelin drugs in solid tumors.Evolving role of bone biomarkers in castration-resistant prostate cancer.Bone metastasis: mechanisms and therapeutic opportunities.Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasisTherapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeletonCombined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesionTargeted therapy in prostate cancer.Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.Role of the endothelin axis and its antagonists in the treatment of cancerBlockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell lineCombinatorial roles for BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the craniofacial skeleton.The PCa Tumor Microenvironment.Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.Atrasentan: targeting the endothelin axis in prostate cancer.Metastasis suppressors and their roles in breast carcinoma.Interactions between microenvironment and cancer cells in two animal models of bone metastasisNew molecular targets in advanced prostate cancer.Chemotherapy resistance in osteosarcoma: current challenges and future directions.Increased Dickkopf-1 expression in breast cancer bone metastases.Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesisProteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.Control of endothelin-a receptor expression by progesterone is enhanced by synergy with Gata2.Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine OsteosarcomaEndothelin receptors and painTransforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers.Luminal breast cancer metastasis is dependent on estrogen signaling.Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
P2860
Q27693653-38145F64-A408-4FE2-8A91-0061D4436773Q28069731-2A8FBCAE-7F12-4F91-861E-A28358E63F67Q30596824-98A6C949-CB5F-4002-8830-4CB2E4667695Q33587901-FC358291-2DEE-4A6E-9CEC-1991A1CC4870Q33686555-0EB4CF67-0248-4D50-AD80-4ABD8085DE8FQ33705995-FC52B625-2023-45D7-AE75-0E5F7104650DQ33803085-5D773694-294A-443A-BD3F-604707FAA641Q33925506-57C1FD31-B9BF-40F3-8A0F-9EDCB011EEF4Q34021011-518A1E7E-05BD-420D-9F80-5D9C14254A10Q34023877-F9B6D84D-69FE-4C97-B8F9-A81AC6A7F3CAQ34025195-2FBC58A8-4FD8-4DAE-A46F-15FD14CD3EE3Q34147824-D187043B-1436-479B-AE38-555E1B65B600Q34159047-D594875E-6917-43F9-94E5-BA096C6FC142Q34574593-3FD2B7FA-F00E-40FA-AF33-6A9D06EE16E8Q34634763-8D0EA1CD-1707-4DFE-93F9-E3370A0C93D7Q34898980-BB0E499A-7491-4D52-8AFF-D9CC8C55032EQ34919570-923E1B3E-78E6-4C1B-AF50-2EEE3AE5EB3EQ35024363-5B8491FC-5D6E-425E-A674-A794A79CA5B0Q35534610-C1B377E0-4BF2-48B8-A141-64F8405DC303Q35603143-22D88255-EF53-4670-B611-9FACB57F3007Q35609713-0EEB42D9-208F-4C0C-922E-91F973AC1F07Q35915066-6A9E6762-A5A5-496C-9D36-8DB8C80CA3BBQ35964727-35AB9236-806B-44CB-A916-34F10A5BC281Q35981102-61446AB9-EC84-49D3-A216-2A86A2170034Q36484558-5081848D-D8C7-4CCE-9508-0A21D0389481Q36532080-4A398BD9-72F2-406A-949D-E44ECEA83E94Q36532115-82EDE1E8-DE1A-4A69-8ED9-389DCDA32007Q36611330-D870AE7F-7ABE-4879-990A-0A2F5D6DBB30Q36689469-03938E67-9AB8-4D3D-8E0F-277E410226B8Q36707418-21AC83E2-66B1-4F09-8E12-789E1A7158B4Q36731426-FD79E01A-4CDD-4AE2-97AC-262B5CB2462FQ36799499-9ADCB0BC-B9F0-4433-BAA6-08BFADDAA19DQ36850156-0BC45B2C-2767-472E-98E2-049A0C1930FDQ36857782-F7364912-0BE1-454E-A044-87D1CBE632E9Q36975672-CDD7FD16-9D73-429D-85ED-A32F8E1BA3B0Q37070713-BBEA6649-43D9-4E5A-882A-449C8EFD6FB1Q37219226-B55CE38A-2C57-461C-A765-1421F0072F27Q37256842-ADF2BF7E-79C8-4FC7-9352-AE313E5D66ACQ37276323-8E6BE701-C252-433A-8554-4FB4B4D60C8DQ37315788-11731CE8-6776-4F04-A207-D5C0C19ED48B
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of endothelin-1 in osteoblastic bone metastases.
@ast
Role of endothelin-1 in osteoblastic bone metastases.
@en
type
label
Role of endothelin-1 in osteoblastic bone metastases.
@ast
Role of endothelin-1 in osteoblastic bone metastases.
@en
prefLabel
Role of endothelin-1 in osteoblastic bone metastases.
@ast
Role of endothelin-1 in osteoblastic bone metastases.
@en
P356
P1433
P1476
Role of endothelin-1 in osteoblastic bone metastases.
@en
P2093
Juan Juan Yin
Khalid S Mohammad
P304
P356
10.1002/CNCR.11129
P407
P433
P577
2003-02-01T00:00:00Z